Process and effect evaluation of a referral aid for smoking cessation counselling in primary care: Findings of a randomized controlled trial

Tob Prev Cessat. 2024 Jan 10:10. doi: 10.18332/tpc/176148. eCollection 2024.

Abstract

Introduction: This study explored the use and effects of a smoking cessation referral in: 1) practice nurses (PNs), and 2) smokers. The use of evidence-based smoking cessation interventions (EBSCIs) can double the likelihood of a successful smoking cessation attempt. A referral aid was developed to aid Dutch PNs in primary care in deciding which smokers are the most suitable for EBSCI.

Methods: Two different studies were conducted: 1) a randomized controlled trial with a process evaluation (n=82) and effect evaluation (n=285) among smoking patients recruited by PNs (n=73), and 2) a process evaluation among a subgroup of PNs (n=40) from January 2019 to September 2020.

Results: Overall, the response in both groups was low. PNs found the referral aid materials clear and understandable. Smokers had similar but (slightly) less-positive opinions. The smokers in both groups did not differ in the amount of discussion and use of EBSCIs, nor on smoking abstinence.

Conclusions: Further research should assess how to better involve PNs and smokers when recruiting for an RCT and how to foster effective counselling. Additional research should also look deeper into barriers to referral of both PNs and smokers, and how to stimulate referral to EBSCIs best and help smokers to make a decision; for example by implementing a simplified strategy both within the primary care setting and outside, by involving other healthcare professionals or options outside healthcare such as the workplace and social domain.

Trial registration: The study was registered at the Netherlands Trial Register (NL7020, https://www.trialregister.nl/trial/7020).

Keywords: evidencebased interventions; general practice; nurse practitioners; primary care; smoking cessation.

Grants and funding

FUNDING This work was supported by ZonMw, The Netherlands Organization of Health Research and Development (Grant number: 531001204).